Disease Management
Measuring IOP in morning, evening critical for disease management
As IOP decreases throughout the day, it is essential for clinicians to evaluate both morning and evening values to effectively monitor IOP-related diseases, according to research published in Cureus.
FDA clears Huma's disease management platform
Huma Therapeutics announced that it has received class II clearance from the FDA for its disease management platform, which facilitates data collection from patients for self-management or remote assessment by health care providers.
IgG4-related disease management still reliant on prednisone as new therapies emerge
DESTIN, Fla. — IgG4-related disease may be regarded as this century’s “greatest mimicker,” but upcoming therapies and discoveries are reasons for excitement, according to a speaker at the 2023 Congress of Clinical Rheumatology-East.
Clinical tool demonstrates validity in assessments for COPD, asthma, type 2 diabetes
A recent study in Annals of Family Medicine confirmed the validity and reliability of a clinical tool in assessing burdens of COPD, type 2 diabetes and asthma.
Effective disease management may help improve sleep quality among those with diabetes
Sleep quality in patients with type 1 diabetes may be improved with disease management as well as interventions supporting resilience and reducing negative emotions, researchers reported in BMC Psychiatry.
VIDEO: Macular disease management unique in patients with advanced glaucoma
NEW YORK — In a presentation at OSN New York Retina, Rajendra S. Apte, MD, PhD, provides insight on managing macular and retinal diseases in patients with advanced glaucoma.
Commentary: Moving toward more objective standards in COPD management
Health care professionals managing COPD are attempting to embrace objective standards in both clinical and research settings.
Celiac Disease Awareness Month: disease management, dietary care, quality of life and more
May is Celiac Disease Awareness Month, and the Celiac Disease Foundation — along with those in the celiac community — have dedicated the month to raising awareness and funds for critical disease research and advocacy efforts.
NLA to unveil new scientific statements, focus on ‘lower is better’ for LDL management
The National Lipid Association Scientific Sessions, a hybrid meeting held Sept. 24-26, 2021, will include four featured sessions, updates on NLA scientific statements and numerous abstract presentations.
ESC adult congenital heart disease guideline stresses lifelong management
The European Society of Cardiology released a new guideline on adult congenital heart disease emphasizing lifelong follow-up and endorsing catheter-based interventions when possible.